Vineeta Agarwala has left her venture partner position at GV, a corporate venturing subsidiary of US-based internet and technology group Alphabet, and joined venture capital firm Andreessen Horowitz as a general partner.
GV (then known as Google Ventures) hired Agarwala in 2015 to join its life sciences team, where she focused on data science and healthcare deals. Her investments included biotechnology companies Locana, Maze Therapeutics and Spero Therapeutics.
Agarwala was also director of product management for cancer research technology producer Flatiron Health, a former GV portfolio company that was acquired by pharmaceutical firm Roche in 2018.
Although it has made some healthcare investments, Andreessen Horowitz has not been a significant participant in the life sciences space. However, general partner Vijay Pande said Agarwala’s experience will help it understand startups that combine computer science technology with healthcare and biopharmaceuticals.
Regarding her appointment, Agarwala said on Twitter: “[I am] thrilled to be joining this amazing team [and I look] forward to working with founders who will change the future of healthcare and make it work better for patients.”
Photo of Vineeta Agarwala courtesy of Twitter.
